Company intelligence / Profile preview

Rx vaistinė

Ownership: Private
Employees: ~8
Development stage: Commercial

Overview

Rx vaistinė is an active Lithuanian pharmacy company founded in 2019. It operates both physical and online pharmacies, offering prescription medicines, over-the-counter products, vitamins, supplements, and other health-related goods. The company collaborates with patient associations and provides information on various health conditions but is not engaged in drug discovery or clinical development

Industry: Non-Academic Healthcare

Drug pipeline

1 asset

diclofenac potassium

Commercial

Indications: Pain, Inflammation

Partnerships

Collaborates with the Lithuanian Hemophilia Association ("Lietuvos žmonių sergančių hemofilija asociacija")

Beyond the preview

Go deeper on Rx vaistinė.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rx vaistinė.

Explore the full profile